Melasma: Its hormonal nature, and why it should be treated holistically

Melasma, a challenging skin condition characterized by brown patches on the face, predominantly affects women, particularly those with darker skin tones. While its exact etiology remains elusive, research indicates that melanocyte-stimulating hormone (MSH) plays a pivotal role in its pathogenesis.

MSH, a hormone secreted by the pituitary gland (in the brain), triggers melanin synthesis, thereby contributing to skin pigmentation. Elevated levels of MSH can exacerbate hyperpigmentation, including melasma.

Various clinical studies underscore the association between MSH and melasma. In a study published in the Journal of Investigative Dermatology, heightened MSH levels correlated with melasma development in pregnant women. Additionally, research in the Journal of the European Academy of Dermatology and Venereology elucidated MSH's role in stimulating melanogenesis, the process leading to hyperpigmentation disorders like melasma.

However, while MSH is pivotal in melasma, its excessive levels can precipitate adverse effects. Studies in the Journal of Clinical Endocrinology & Metabolism suggest that elevated MSH levels may contribute to conditions like Cushing's syndrome and Addison's disease, both of which manifest as skin hyperpigmentation.

Effectively managing melasma necessitates a multifaceted approach targeting its current manifestation and thwarting its recurrence. Here's a comprehensive strategy supported by research:

Topical Treatments:

Vitamin C: Known for its antioxidant properties, vitamin C can help brighten the skin and reduce pigmentation. A study in the Journal of Clinical and Aesthetic Dermatology demonstrated the efficacy of topical vitamin C in treating melasma.
Azelaic Acid: Renowned for its depigmenting properties, azelaic acid inhibits melanin synthesis and reduces inflammation. Research in the Journal of the European Academy of Dermatology and Venereology highlights its effectiveness in treating melasma.

Technological Interventions:

Microneedling: Employing techniques that direct melanogenesis regulators towards melanocytes can mitigate melasma appearance. Studies, such as one in the Journal of Cosmetic Dermatology, demonstrate significant melasma improvement post-microneedling.
Chemical Peels: Chemical peels exfoliate the skin, promoting cell turnover and reducing pigmentation. Research in the Journal of the American Academy of Dermatology underscores the efficacy of chemical peels in melasma management.
Laser Therapy: Various laser technologies, such as fractional laser and intense pulsed light (IPL), can target melanin in the skin and reduce pigmentation. Research in the Journal of the American Academy of Dermatology showed promising results with laser therapy in treating melasma.

Oral Supplements:

Oral Tranexamic Acid: This systemic medication mitigates melanin production and effectively treats melasma. Studies, such as one in the Journal of Dermatological Treatment, affirm oral tranexamic acid's role in melasma amelioration.
Beta Carotene: An oral supplement rich in antioxidants, beta carotene aids in skin health and may complement melasma management strategies.
In conclusion, comprehending MSH's role in melasma pathogenesis is pivotal for devising efficacious treatment modalities.

By integrating topical agents, technological interventions, and oral supplements, individuals can effectively navigate melasma, diminishing its current appearance and forestalling future recurrences for a luminous, uniform complexion.

Products and services in our range you might consider if you experience this concern: